Skip to main content

Research Repository

Advanced Search

Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms—authors' reply

Gunn, David; Ford, Alexander; Farrin, Amanda; Spiller, Robin

Authors

David Gunn

Alexander Ford

Amanda Farrin

Profile Image

ROBIN SPILLER ROBIN.SPILLER@NOTTINGHAM.AC.UK
Professor of Gastroenterology



Citation

Gunn, D., Ford, A., Farrin, A., & Spiller, R. (2023). Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms—authors' reply. Alimentary Pharmacology and Therapeutics, 57(11), 1337-1338. https://doi.org/10.1111/apt.17496

Journal Article Type Editorial
Acceptance Date May 1, 2023
Online Publication Date May 9, 2023
Publication Date 2023-06
Deposit Date Jun 12, 2023
Publicly Available Date May 10, 2024
Journal Alimentary Pharmacology & Therapeutics
Print ISSN 0269-2813
Electronic ISSN 1365-2036
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 57
Issue 11
Pages 1337-1338
DOI https://doi.org/10.1111/apt.17496
Keywords Pharmacology (medical); Gastroenterology; Hepatology
Public URL https://nottingham-repository.worktribe.com/output/20567253
Publisher URL https://onlinelibrary.wiley.com/doi/10.1111/apt.17496
Additional Information This article is linked to Gunn et al papers. To view these articles, visit https://doi.org/10.1111/apt.17426 and https://doi.org/10.1111/apt.17462